Skip to main content
Premium Trial:

Request an Annual Quote

You Want the Good News, or the Bad News?

Premium

According to researchers, children who have survived cancer are at increased risk of developing secondary tumors, says Reuters' Frederik Joelving. Gregory Armstrong from St. Jude Children's Research Hospital tell Reuters that skin cancers — which could be considered relatively harmless under normal circumstances — appear to be early warning signs of more aggressive disease in such kids. In a new study published by Armstrong and his team in the Journal of Clinical Oncology, the researchers found that such skin cancers could be a biomarker of risk in such patients, Joelving says. The study tracked about 14,000 kids who had survived cancer for at least five years, for up to 38 years after diagnosis — five percent developed a new cancer, Joelving says. The risk for a third cancer was 12 percent in patients who had already beaten cancer twice, and the risk was increased for patients who had received radiation as part of their treatment, he adds. Armstrong says this study makes the case for keeping a closer eye on survivors of childhood cancer, and that such patients must be diligent about seeing their doctors. The good news, he adds, is that many more children are being cured of cancer now than they were 50 years ago.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more